ProfileGDS4718 / 201496_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 77% 100% 57% 69% 48% 42% 54% 64% 53% 50% 56% 45% 57% 42% 87% 51% 46% 45% 49% 79% 61% 74% 62% 73% 45% 66% 48% 47% 37% 49% 97% 55% 41% 86% 52% 48% 54% 52% 100% 52% 37% 95% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4906550
GSM549102patient 115, normal, homogenized [OPG study]7.4957577
GSM549104patient 119, normal, homogenized [OPG study]13.8571100
GSM549108patient 138, normal, homogenized [OPG study]5.9502557
GSM549119patient 077, normal, homogenized [OPG study]6.7276969
GSM549133patient 032, cancer, homogenized [OPG study]5.3333848
GSM549139patient 042, cancer, homogenized [OPG study]5.0744142
GSM549099patient 107, normal, homogenized [OPG study]5.7273354
GSM549109patient 139, normal, homogenized [OPG study]6.4308164
GSM549110patient 046, normal, homogenized [OPG study]5.6917253
GSM549114patient 063, normal, homogenized [OPG study]5.440350
GSM549122patient 082, normal, homogenized [OPG study]5.8634756
GSM549134patient 033, cancer, homogenized [OPG study]5.2363245
GSM549136patient 036, cancer, homogenized [OPG study]5.8769657
GSM549140patient 044, cancer, homogenized [OPG study]5.0607342
GSM549111patient 047, normal, homogenized [OPG study]8.7914887
GSM549113patient 057, normal, homogenized [OPG study]5.5111751
GSM549132patient 031, cancer, homogenized [OPG study]5.2600646
GSM549137patient 038, cancer, homogenized [OPG study]5.212845
GSM549142patient 047, cancer, homogenized [OPG study]5.5838649
GSM549100patient 110, normal, homogenized [OPG study]7.629579
GSM549107patient 135, normal, homogenized [OPG study]6.1592561
GSM549115patient 068, normal, homogenized [OPG study]7.3232374
GSM549116patient 072, normal, homogenized [OPG study]6.244262
GSM549120patient 078, normal, homogenized [OPG study]7.1106773
GSM549131patient 030, cancer, homogenized [OPG study]5.1862145
GSM549118patient 074, normal, homogenized [OPG study]6.590266
GSM549129patient 027, cancer, homogenized [OPG study]5.4251348
GSM549123patient 088, normal, homogenized [OPG study]5.3445847
GSM549124patient 006, cancer, homogenized [OPG study]4.8783637
GSM549126patient 015, cancer, homogenized [OPG study]5.4437249
GSM549128patient 025, cancer, homogenized [OPG study]10.827897
GSM549103patient 117, normal, homogenized [OPG study]5.8525555
GSM549117patient 073, normal, homogenized [OPG study]5.0262241
GSM549138patient 041, cancer, homogenized [OPG study]8.5862786
GSM549141patient 045, cancer, homogenized [OPG study]5.5833652
GSM549130patient 028, cancer, homogenized [OPG study]5.4021948
GSM549101patient 111, normal, homogenized [OPG study]5.7882854
GSM549105patient 128, normal, homogenized [OPG study]5.6760752
GSM549106patient 134, normal, homogenized [OPG study]13.8066100
GSM549112patient 048, normal, homogenized [OPG study]5.6324952
GSM549125patient 011, cancer, homogenized [OPG study]4.8660937
GSM549127patient 024, cancer, homogenized [OPG study]10.019595
GSM549135patient 035, cancer, homogenized [OPG study]5.029442